天津医药

• 短篇论著 • 上一篇    下一篇

乳腺癌术后即刻与延期乳房再造的比较

杨景明1,张学慧2   

  1. 1. 天津市大港医院外二科
    2. 天津医科大学附属肿瘤医院
  • 收稿日期:2011-09-26 修回日期:2011-11-10 出版日期:2012-08-15 发布日期:2012-08-15
  • 通讯作者: 杨景明

Outcome of different timings in transverse rectus abdominis myocutaneous breast reconstruction after the breast cancer operation

  • Received:2011-09-26 Revised:2011-11-10 Published:2012-08-15 Online:2012-08-15

PDF (PC)

2410

摘要： 【摘要】目的 比较乳腺癌术后即刻与延期转移下腹部横行腹直肌肌皮瓣乳房再造(TRAM)的临床效果及最佳手术时机 方法 选择临床Ⅰ、Ⅱ期乳腺癌患者78例，按照TRAM乳房再造的时间不同，分为即刻再造组和延期再造组，即刻再造组患者在乳腺癌手术的同时行乳房再造；延期再造组患者在乳腺癌手术后6～12个月行乳房再造，比较两组患者术后乳房外观、并发症及其它临床相关情况 结果 两组患者乳房外观满意率、平均住院时间、治疗费用比较，均具有统计学差异(P＜0.05)；术后并发症、术后2年及5年生存生存率比较，均无统计学差异(P＞0.05) 结论 TRAM即刻乳房再造，可提高患者乳房外观满意率，缩短住院时间，减少治疗费用，同时减少术后并发症，对患者的生存率无影响。

关键词: 乳腺癌, TRAM, 乳房再造, 手术时机

Abstract: 【Abstract】Objective: To observe the clinical effects of transverse rectus abdominis myocutaneous (TRAM) breast reconstruction after the breast cancer operation and to estimate the timing of TRAM breast reconstruction after the breast cancer operation. Method: In our study, 78 patients with stage Ⅰ or stageⅡ breast cancer were involved. The population was stratified into two groups: group 1, immediate breast reconstruction after mastectomy (n = 46 patients); and group 2, breast reconstruction within 6-12 months after surgery (n = 32 patients). Outcomes of both groups were evaluated including satisfaction, hospital stay, postoperative complications and so on. Result: There was a statistic significance(P＜0.05) between two groups with regard to appearance satisfaction, hospital stay and average cost of treatment; While the postoperative complications, survival of patients after postoperative 2 years and 5 years were similar in both groups。 Conclusion: Our outcomes implied that immediate TRAM breast reconstruction after mastectomy is a reliable and safe technique with high patient satisfaction, short hospital stay, shrinkage of the cost, low complication rates and similar survival rate.

Key words: Breast cancer, TRAM, Breast reconstruction, Operation time